Liraglutide
Individualized Obesity Pharmacotherapy
Novo Nordisk · Phase 3 · Completed · Enrollment 193
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Intervention group | Obesity or overweight | n/r | n/r | n/r | n/r |
| Control Group | Obesity or overweight | n/r | n/r | n/r | n/r |